Table: Zeria Pharm -Q1 group results

Zeria Pharmaceutical

04/08/2022 08:00

Aug 4 (Reuters)- 
             Zeria Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Jun 30, 2022        Jun 30, 2021     Mar 31, 2023 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             16.31               13.55            66.00    
                 (+20.3 pct)         (+6.4 pct)       (+10.9 pct) 
  Operating          2.98                1.25             7.00    
                (+137.8 pct)         (+18.3 pct)      (+10.0 pct) 
  Recurring          2.97                2.08             7.00    
                 (+42.9 pct)        (+229.1 pct)      (+17.9 pct) 
  Net                2.60                1.41             5.60    
                 (+84.6 pct)         (+44.8 pct)      (+41.4 pct) 
  EPS             58.71 yen           30.91 yen       126.72 yen  
  Ann Div                             35.00 yen        36.00 yen  
  -Q2 div                             17.00 yen        18.00 yen  
  -Q4 div                             18.00 yen        18.00 yen  
  
  NOTE - Zeria Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4559.T